lymphomas 2002 05 slides

Upload: violaorsino

Post on 04-Jun-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/13/2019 Lymphomas 2002 05 Slides

    1/61

  • 8/13/2019 Lymphomas 2002 05 Slides

    2/61

    History

    Thomas Hodgkin 1798-1866 Guys Hospital, London

    Accomplishments: Clinicopathologic correlation (pre-microscope) Appendicitis c peritonitis

    Local spread of cancer to nodes

    Brought stethoscope to England (Laennac) Histology of RBCs, muscle (Lister)

    Aortic insufficiency

    Public health (cholera, lead pipes)

  • 8/13/2019 Lymphomas 2002 05 Slides

    3/61

    History

    Thomas Hodgkin 1798-1866 (cont)LAD: cancer, inflammation, TB, syphilis

    1832 On Some Morbid Appearances of theAbsorbent Glands and Spleen

    Six cases of LAD s pain, heat, or primary tumor

    Billrothmalignant lymphomas

  • 8/13/2019 Lymphomas 2002 05 Slides

    4/61

    Lymphoproliferative Disorders

    Benign reactive lymphoproliferativedisorders

    Histiocytosis X (Langerhans-cell) Plasma call neoplasms

    Lymphomas

    Non-Hodgkins lymphomas Hodgkins Disease

  • 8/13/2019 Lymphomas 2002 05 Slides

    5/61

    Immunology Review

    Blood WBCs

    Lymphocytes

    B-cells T-cells

    NK-cells

    Major histocompatibility complex (MHC)

    I: all cellsII: immune cells

  • 8/13/2019 Lymphomas 2002 05 Slides

    6/61

    Immunology Review

    B-cellsBursa of Fabricius

    Secrete immunoglobulin

    Ig A, D, E, G, M

    T-cellsThymus, thymic education

    Tc, Th1, Th2, Ts

    NK cellsNon-specific, no memory

  • 8/13/2019 Lymphomas 2002 05 Slides

    7/61

    Lymphocyte Differentiation

  • 8/13/2019 Lymphomas 2002 05 Slides

    8/61

    B-Cell Development

  • 8/13/2019 Lymphomas 2002 05 Slides

    9/61

    Tumorigenesis

  • 8/13/2019 Lymphomas 2002 05 Slides

    10/61

  • 8/13/2019 Lymphomas 2002 05 Slides

    11/61

    Techniques for Investigation

    Cytogenetics

    Immunohistochemistry

    FISH Flow Cytometry

  • 8/13/2019 Lymphomas 2002 05 Slides

    12/61

    Cytogenetics

    t(14,18) common (about 30%)Bcl-2

    Follicular growth pattern

    t(8,14)common in Burkittsc-myc

    Multiple anomalies common

    Correlation between cytogenetic change andoutcome is variable

  • 8/13/2019 Lymphomas 2002 05 Slides

    13/61

    Cytogenetics

  • 8/13/2019 Lymphomas 2002 05 Slides

    14/61

    Cytogenetics

  • 8/13/2019 Lymphomas 2002 05 Slides

    15/61

    Immunohistochemistry

  • 8/13/2019 Lymphomas 2002 05 Slides

    16/61

    Immunohistochemistry

  • 8/13/2019 Lymphomas 2002 05 Slides

    17/61

    Immunohistochemistry

  • 8/13/2019 Lymphomas 2002 05 Slides

    18/61

    Immunohistochemistry

  • 8/13/2019 Lymphomas 2002 05 Slides

    19/61

    ClassificationHD

  • 8/13/2019 Lymphomas 2002 05 Slides

    20/61

    Reed-Sternberg Cell

    Described 1898 Sternberg, 1902 Reed

    Popcorn cell variant

  • 8/13/2019 Lymphomas 2002 05 Slides

    21/61

    Lymphocyte-PredominantMixed Cellularity

    Lymphocyte-Depleted Nodular Sclerosis

    Lacunar cell

  • 8/13/2019 Lymphomas 2002 05 Slides

    22/61

    ClassificationNHLs

    Rappaport1956Nodular vs. diffuse

    Lymphocytes vs. histiocytes

    Kiel, Lukes-Collins, BNLI, Dorfman, WHO

    Working Formulation1982

    Revised European-American LymphomaClassification (REAL)1994

    From International Lymphoma Study Group

  • 8/13/2019 Lymphomas 2002 05 Slides

    23/61

    Rappaport

  • 8/13/2019 Lymphomas 2002 05 Slides

    24/61

    Kiel

  • 8/13/2019 Lymphomas 2002 05 Slides

    25/61

    Kiel

  • 8/13/2019 Lymphomas 2002 05 Slides

    26/61

    Working Formulation (1982)

    Designed to be a translational schemebetween others, became free-standing

    Essentially modified from RappaportHistiocyticLarge cell

    Not based on cell of originBased on survival to 1970s chemo

    H&E only, no special stains Test/Retest 0.53-0.93

    Interobserver concordance 0.21-0.65

  • 8/13/2019 Lymphomas 2002 05 Slides

    27/61

    Working Formulation

  • 8/13/2019 Lymphomas 2002 05 Slides

    28/61

    Non-Hodgkins Lymphomas

  • 8/13/2019 Lymphomas 2002 05 Slides

    29/61

    Small lymphocytic Small cleaved Mixed,

    Small cleaved

    and large cell

  • 8/13/2019 Lymphomas 2002 05 Slides

    30/61

    Large cell,

    Cleaved and

    Non-cleaved

    Mixed,

    Non-cleaved

    Large cell,

    Non-cleaved

  • 8/13/2019 Lymphomas 2002 05 Slides

    31/61

    REAL (1994)

  • 8/13/2019 Lymphomas 2002 05 Slides

    32/61

    REAL

  • 8/13/2019 Lymphomas 2002 05 Slides

    33/61

    Staging

  • 8/13/2019 Lymphomas 2002 05 Slides

    34/61

    LN Zones

  • 8/13/2019 Lymphomas 2002 05 Slides

    35/61

    Epidemiology

  • 8/13/2019 Lymphomas 2002 05 Slides

    36/61

    Epidemiology

  • 8/13/2019 Lymphomas 2002 05 Slides

    37/61

    Epidemiology

  • 8/13/2019 Lymphomas 2002 05 Slides

    38/61

    Hodgkins Disease

    Bimodal peak

    Incidence decreasing

    Geographic variation

  • 8/13/2019 Lymphomas 2002 05 Slides

    39/61

    EpidemiologyHodgkins

    Bimodal

    Postulated tohave

    infectious

    association

  • 8/13/2019 Lymphomas 2002 05 Slides

    40/61

    EpidemiologyHodgkins

  • 8/13/2019 Lymphomas 2002 05 Slides

    41/61

    EpidemiologyHodgkins

  • 8/13/2019 Lymphomas 2002 05 Slides

    42/61

    EpidemiologyHodgkins

  • 8/13/2019 Lymphomas 2002 05 Slides

    43/61

    EpidemiologyNHLs

  • 8/13/2019 Lymphomas 2002 05 Slides

    44/61

    EpidemiologyNHLs

  • 8/13/2019 Lymphomas 2002 05 Slides

    45/61

    EpidemiologyNHLs

  • 8/13/2019 Lymphomas 2002 05 Slides

    46/61

    Epidemiology

  • 8/13/2019 Lymphomas 2002 05 Slides

    47/61

    EpidemiologyHIV

    Anti-retroviral tx has decreased incidence

  • 8/13/2019 Lymphomas 2002 05 Slides

    48/61

    Workup

    H & P

    Usually FNAr/o SCCaexcisional bxif lymphoma for architecture, flow cyt.

    Chemistries, CBC c smear, LFTs c LDH,ESR, beta-2 microglobulin

    CT chest, abdomen, pelvis

    Bone marrow (MR directed?) Adjunct: Gallium, FDG-PET

  • 8/13/2019 Lymphomas 2002 05 Slides

    49/61

    HD vs. NHLClinical Exam

  • 8/13/2019 Lymphomas 2002 05 Slides

    50/61

    Gallium Scan

    Gallium-67 isotope

    Affinity for lymphomas

    Good sensitivity/specificity If treatment makes Ga scan negative, good

    chance at lasting remission

    May find occult disease

  • 8/13/2019 Lymphomas 2002 05 Slides

    51/61

    Gallium Scan

  • 8/13/2019 Lymphomas 2002 05 Slides

    52/61

    FDG-PET

    PETpositron emission tomography

    FDG18-fluoro deoxy-glucose

    Taken by actively metabolic cells Good sensitivity/specificity

  • 8/13/2019 Lymphomas 2002 05 Slides

    53/61

    Staging Laparotomy

    Looks for infradiaphragmatic disease Important if disease o/w would be Stage I/II

    supradiaphragmatic

    May change Tx Largely supplanted by non-invasive techniques

    Not complication-free

    Laparoscopy?

    Controversial

  • 8/13/2019 Lymphomas 2002 05 Slides

    54/61

    Burkitts Lymphoma

    AfricanendemicUsually presents in

    maxilla or mandible

    EBV ++

    SporadicSome EBV

  • 8/13/2019 Lymphomas 2002 05 Slides

    55/61

    Lethal Midline Granuloma

    Polymorphic reticulosis

    Lymphomatoid granulomatosis

    Idiopathic midline destructive disease Clinically similar to Wegeners

    No granulomas or histiocytes

    Poor survivial

  • 8/13/2019 Lymphomas 2002 05 Slides

    56/61

    Treatment

    ChemoHD: MOPP, ABVD

    NHLs: CHOP

    Radiation

    Bone marrow transplant

    ImmunotxRituxananti-CD20

  • 8/13/2019 Lymphomas 2002 05 Slides

    57/61

    Case Report

    34 yo WM c/o night sweats

    Saw ID MD, told he had CMV

    2 years later, still night sweats Trouble shaving due to fullness in neck

    BiopsyNon-Hodgkins Lymphoma, low-

    grade Bone marrow ++, both sides diaphragm

  • 8/13/2019 Lymphomas 2002 05 Slides

    58/61

    Case Report

    Rituxan, chemoDisease came back when off

    Bone marrow transplant, allogeneic ++ Richters transformation

    GVHD

    Expired

  • 8/13/2019 Lymphomas 2002 05 Slides

    59/61

    Fierstein JT, Thawley SE. Lymphoma of the head and neck. Laryngoscope88:582-93, 1988.Fisher RI. Current therapeutic paradigm for the treatment of non-Hodgkins lymphoma. Semin Oncol27 (suppl12) 2 8 2000

  • 8/13/2019 Lymphomas 2002 05 Slides

    60/61

    12):2-8, 2000.Gaynor ER, Fisher RI. Aggressive non-Hodgkins lymphoma. In Jancock BW, Selby PJ, MacLennan K, ArmitageJO (eds)Malignant Lymphoma.Arnold: London, 2000.Gledovic Z, Radovanovic Z. History of tonsillectomy and appendectomy in Hodgkins disease. Eur J Epidemiol7:612, 1991.Goldberg D, Golz A, Netzer A, et al. Epstein-Barr virus and cancers of the head and neck. Am J Otolaryngol

    22(3):197-205, 2001.Green JD, Neel HB, Witzig TE. Lymphoproliferative disorders of the head and neck. Am J Otolaryngol12:26-32,1991.Griesser H, Mak TW. Developmental and functional biology of B and T lymphocytes. In Canellos GP, Lister TA,Sklar JL, (eds) The Lymphomas. Saunders: Philadelphia, 1998.Grillo-Lopez AJ. Rituximab: an insiders historical perspective. Seminars in Oncology27(6) suppl 12 (Dec):9-16,2000.Gupta RK, Gospodarowicz, Lister TA. Clinical evaluation and staging of Hodgkins disease. In Mauch PM,Armitage JO, Diehl V, et al (eds)Hodgkins Disease. Lippincott: Philadelphia, 1999.Hanna E, Wanamaker J, Adelstein D, et al. Extranodal lymphomas of the head and neck: a 20-year experience. ArchOtolaryngol Head Neck Surg 123:1318-23, 1997 Dec.Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: A proposalfrom the International Lymphoma Study Group. Blood84:1361-92, 1994.Hauke RJ, Armitage JO. Treatment of non-Hodgkin lymphoma. Curr Opin Oncol12:412-8, 2000.Healy GB. Malignant tumors of the head and neck in children: diagnosis and treatment. Otolaryngol Clin North Am13(3):483-8, 1980 Aug.Hellmann S. A brief consideration of Thomas Hodgkin and his times. In Mauch PM, Armitage JO, Diehl V, et al

    (eds)Hodgkins Disease Lippincott: Philadelphia, 1999.Jacobs C, Weiss L, Hoppe RT. The management of extranodal head and neck lymphomas. Arch Otolaryngol HeadNeck Surg 112:654-8, 1986 Jun.Jaffe ES. Histopathology of the non-Hodgkin's lymphomas and Hodgkin's disease. In Canellos GP, Lister TA, SklarJL, (eds) The Lymphomas. Saunders: Philadelphia, 1998.Josting A, Wolf J, Diehl V. Hodgkin disease: prognostic factors and treatment strategies. Curr Opin Oncol12:403-11, 2000.Kaplan WD, Jochelson MS, Herman TS, et al. Gallium-67 imaging: a predictor of residual tumor viability and

    clinical outcome in patients with diffuse large-cell lymphoma. J Clin Oncol 8:1966-70, 1990.

    Kl i G Kl i E E i B i d h l h I C ll GP Li TA Skl JL ( d ) Th L h S d

  • 8/13/2019 Lymphomas 2002 05 Slides

    61/61

    Klein G, Klein E. Epstein-Barr virus and human lymphomas. In Canellos GP, Lister TA, Sklar JL, (eds) The Lymphomas Saunders:Philadelphia, 1998.Lin AY, Tucker MA. Epidemiology of Hodgkins disease and non-Hodgkins lymphoma. In Canellos GP, Lister TA, Sklar JL, (eds)The Lymphomas. Saunders: Philadelphia, 1998.Mantravadi RVP. Radiation therapy for nonsquamous tumors of the head and neck. Otolaryngol Clin North Am19(4):741-54, 1986

    Nov.Mendenhall NP, Hoppe RT, Prosnitz LR, Mauch PM. Principles of radiation therapy in Hodgkins disease. In Mauch PM, Armitage

    JO, Diehl V, et al (eds)Hodgkins Disease Lippincott: Philadelphia, 1999.Mueller NE, Grufferman S. The epidemiology of Hodgkins disease. In Mauch PM, Armitage JO, Diehl V, et al (eds)Hodgkins

    Disease. Lippincott: Philadelphia, 1999.Ng AK, Hoppe RT, Mauch PM. Life expectancy of patients with Hodgkins disease. In Mauch PM, Armitage JO, Diehl V, et al (eds)Hodgkins Disease Lippincott: Philadelphia, 1999.Pratt BL, Greene FL. Role of laparoscopy in the staging of malignant disease. Surg Clin North Am80(4):1111-26, 2000 Aug.Rabkin CS, Ward MH, Manns A, Blattner WA. Epidemiology of non-Hodgkins lymphomas. In Magrath I (ed) The Non-Hodgkins

    Lymphomas. Arnold: London, 1997.Robbins KT, Fuller LM, Vlasak M, et al. Primary lymphomas of the nasal cavity and paranasal sinuses. Cancer56:814-9, 1985.Shipp, MA, Harrington DP, Anderson JR, et al. A predictive model for aggressive non-Hodgkins lymphoma. N Engl J Med 329:987-

    94, 1993.Shivapurkar N, Harada K, Reddy J, et al. Presence of simian virus 40 DNA sequences in human lymphomas.Lancet 359(9309):851-2,2002 Mar 9.Sklar JL. Introduction to molecular biology. In Canellos GP, Lister TA, Sklar JL, (eds) The Lymphomas. Saunders: Philadelphia, 1998.Specht L. Staging systems and staging investigations. In Magrath I (ed) The Non-Hodgkins Lymphomas. Arnold: London, 1997.Stein H, Diehl V, Marafioti T, Jox A, et al. The nature of Reed-Sternberg cells, lymphocytic and histiocytic cells and their molecular

    biology in Hodgkins disease. In Mauch PM, Armitage JO, Diehl V, et al (eds)Hodgkins Disease. Lippincott: Philadelphia, 1999.The Non-Hodgkins Lymphoma Pathologic Classification Project. National Cancer InstituteSponsored Study of Classifications of

    Non-Hodgkins Lymphomas: summary and description of a working formulation for clinical usage. Cancer49:2112-35, 1982.Vose JM, Armitage JO. Bone marrow transplantation for non-Hodgkins lymphomas. In Magrath I (ed) The Non-Hodgkins

    Lymphomas. Arnold: London, 1997.Weiss LM, Chan JKC, MacLennan K, Warnke RA. Pathology of classical Hodgkins disease. In Mauch PM, Armitage JO, Diehl V, etal (eds)Hodgkins Disease. Lippincott: Philadelphia, 1999.Winkler U, Engert A, Diehl V. Novel techniques in Hodgkins disease. In Mauch PM, Armitage JO, Diehl V, et al (eds)Hodgkins

    Disease Lippincott: Philadelphia, 1999.Yahlom J. Radiation therapy in the treatment of lymphoma. Curr Opin Oncol11:370-4, 1999.